Article
Molecular alterations in meningioma: prognostic and therapeutic perspectives
2 Sept 2020
Abstract excerpt
PURPOSE OF REVIEW: To discuss recent advances in the meningioma biology and their clinical implications. RECENT FINDINGS: Meningioma is the most common primary intracranial tumor. Mostly benign, 20% of cases display an aggressive behavior despite best standard of care. The genetic landscape of meningiomas is divided according to NF2 mutational status. Although about 60% of meningiomas display NF2 mutations, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
